The suit claims that Arizona-based Insys Therapeutics gave kickbacks to doctors who prescribed its products and used fraudulent tactics to get more people prescribed, including falsifying medical histories.
Beshear said the company’s fentanyl-based mouth spray Subsys was only approved for cancer patients but the company aggressively marketed the pain medication to get more patients prescribed.
“Insys sought to line their pockets by fraudulently acquiring insurance coverage approvals, giving kickbacks to doctors and incentivizing its sales force to engage in fraudulent and deceitful conduct,” Beshear said.
This summer, the company also reached a $150 million settlement with the U.S. Department of Justice over its sales practices.
The lawsuit is the ninth Beshear has filed against an opioid distributor or manufacturer over the last year as Kentucky’s drug overdose death rate continues to climb every year.
In 2017, 1,565 people died of drug overdoses in the state, up from 1,404 in 2016.
This story has been updated.